JAMIE RESTIVO: Open Payments
NPI 1013415264 · ENOLA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,768 in 67 payments from 18 companies in 2025. Trend: 2023 $1,720 · 2024 $2,033 · 2025 $2,768
Food & beverage: $1,331Consulting: $1,140Education: $297
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $1,389 |
| Janssen Biotech, Inc. | 11 | $296 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $169 |
| Regeneron Healthcare Solutions, Inc. | 5 | $168 |
| Galderma Laboratories, L.P. | 8 | $156 |
| ABBVIE INC. | 8 | $137 |
| LEO Pharma Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Almirall LLC | 2 | $42 |
Products named: Bimzelx, TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, ADBRY, COSENTYX, Klisyri.
Industry payments across PA — which companies pay providers there.
